highly significantP <0.001
Pain assessment in patients showed highly significant change from baseline VAS score to 4 th week of the therapy in gabapentin groups ( P <0.001) as compared to placebo.
Pain assessment in patients showed highly significant change from baseline VAS score to 4 th week of the therapy in gabapentin groups ( P <0.001) as compared to placebo.